STI
15
-6
UPS
40
2
CPB
37
2
IBM
67
2
C
85
3
LOW
45
2
ES
50
3
AZO
46
-2
SJM
14
3
F
58
2
VTR
70
3
EXC
53
3
PHM
43
2
SLG
37
6
MO
57
4
DRI
64
4
XYL
35
2
LNC
70
-2
CNP
55
3
AEE
58
3
STI
15
-6
UPS
40
2
CPB
37
2
IBM
67
2
C
85
3
LOW
45
2
ES
50
3
AZO
46
-2
SJM
14
3
F
58
2
VTR
70
3
EXC
53
3
PHM
43
2
SLG
37
6
MO
57
4
DRI
64
4
XYL
35
2
LNC
70
-2
CNP
55
3
AEE
58
3
Financhill
Back

JPMorgan Ultra-Short Income ETF Vs. Cidara Therapeutics, Inc. Industry Stock Comparison

Sell
40

JPST
JPMorgan Ultra-Short Income ETF

Last Price:
$50.73
Seasonality Move:
-0.02%
Buy
80

CDTX
Cidara Therapeutics, Inc.

Last Price:
$220.90
Seasonality Move:
-5.43%
Sell
40
JPMorgan Ultra-Short Income ETF (JPST) is a Sell

Is JPMorgan Ultra-Short Income ETF a Buy, Sell or Hold?

  • The current JPMorgan Ultra-Short Income ETF [JPST] share price is $50.73. The Score for JPST is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • JPST is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
80
Cidara Therapeutics, Inc. (CDTX) is a Buy

Is Cidara Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Cidara Therapeutics, Inc. [CDTX] share price is $220.86. The Score for CDTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

JPST Stock Price Chart

What is JPMorgan Ultra-Short Income ETF's stock price today?

  • The JPMorgan Ultra-Short Income ETF share price today is $50.73
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JPST is experiencing buying pressure, which is a positive indicator for future bullish movement.

CDTX Stock Price Chart

What is Cidara Therapeutics, Inc.'s stock price today?

  • The Cidara Therapeutics, Inc. share price today is $220.86
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing slight buying pressure.

JPST Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 65.53 Buy
Chaikin Money Flow: 3962706 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (50.61 - 50.71) Buy
Bollinger Bands (100): (50.6 - 50.72) Buy

CDTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 12.96 Buy
Relative Strength Index (14 RSI): 85.13 Buy
Chaikin Money Flow: 25719 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (219.65 - 220.67) Buy
Bollinger Bands (100): (58.67 - 185.13) Buy

JPST Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 50.68 Buy
20-day SMA: 50.66 Buy
50-day SMA: 50.67 Buy
200-day SMA: 50.6 Buy
8-day EMA: 50.69 Buy
20-day EMA: 50.67 Buy
50-day EMA: 50.66 Buy
200-day EMA: 50.61 Buy

CDTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 220.52 Buy
20-day SMA: 220.3 Buy
50-day SMA: 168.33 Buy
200-day SMA: 76.74 Buy
8-day EMA: 220.52 Buy
20-day EMA: 213.21 Buy
50-day EMA: 178.71 Buy
200-day EMA: 98.26 Buy

JPMorgan Ultra-Short Income ETF Earnings Growth & JPST Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Cidara Therapeutics, Inc. Earnings Growth & CDTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.86 per share, and an increase next year of $1.78 per share.

JPMorgan Ultra-Short Income ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cidara Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):